RSS   Newsletter   Contact   Advertise with us
Post Online Media

Stellar Biotechnologies appoints two to board

Stellar BiotechnologiesStellar Biotechnologies, a manufacturer of a key protein utilized in multiple immunotherapy development pipelines, appoints Charles V. Olson and Paul Chun to the company's board of directors.
Article continues below

READ MORE Stellar Biotechnologies adds Malcolm Gefter to corporate board and SAB

Dr. Olson has been a member of Stellar's scientific advisory board since June 2014 and has extensive scientific, manufacturing and senior management experience in the biotechnology and pharmaceutical industries.

Dr. Olson is currently Chief Technology Officer at Anthera Pharmaceuticals, Inc. and is a Principal Biotechnology Consultant for Compass Biotechnology LLC.

Mr. Chun is Managing Partner and founder of Eldred Advisors LLC, an advisory firm specializing in the life sciences.

Mr. Chun brings broad experience as an investment analyst and strategic advisor to the Board, including expertise in therapeutics development and commercialization, corporate development, strategy and finance.

Mr. Chun's previous work includes roles at Goldman, Sachs & Co., Tavistock Life Sciences Co., Amgen, Inc., and Westwicke Partners, LLC.



We use cookies to ensure that we give you the best experience on our website. Please allow cookies for fully-functioning website.

Allow Cookies Privacy Policy